Revalid’s growth-boosting hair care system is now complete!
Made in Switzerland, the Revalid system for hair loss comprises the brand-new Revalid Stimulating Shampoo and the Revalid Regrowth Serum . Both shampoo and serum contain the innovative active ingredient Redensyl. This cutting-edge ingredient is a blend of patented molecules, developed to reinvigorate the cells in the follicles responsible for hair growth. Drawn from the larch tree and green tea leaves, these molecules are combined with zinc and the amino acid, glycine. This innovative combination serves to boost the initiation of new hair growth cycles while nourishing and strengthening the hair from the root.
Revalid Stimulating Shampoo has been formulated with Swiss Artemisia extract and panthenol, so not only does it gently cleanse the hair and scalp but also provides vital moisture and hydration for the hair, strengthening the hair structure. This way the hair receives the care it needs and is in optimal condition for treatment with Revalid Regrowth Serum , which can be applied directly after washing to wet or dry hair.
Noticeable improvement in the majority of testers
Drawn from the field of regenerative medicine research, Redensyl has been found to increase hair density by 8%* – which corresponds to 28,000 new hairs after three months of daily use. After 84 days, the majority of testers reported a noticeable improvement in their hair loss and said they would purchase the products themselves.
*In a double-blind, placebo controlled clinical trial under the supervision of trained dermatologists with 3% Redensyl
Revalid was developed in 1992 in Switzerland specifically for holistic hair care and to treat hair loss. The high-quality Swiss Hair Care System consists of a course of medicinal capsules for oral ingestion and a range of hair cosmetics for external application. All products are dermatologically tested and produced in Switzerland. www.revalid.com
Ewopharma AG, headquartered in Schaffhausen (Switzerland) is the innovative partner for the marketing of pharmaceuticals and consumer health products in Central Eastern Europe. With over 60 years’ presence in the region, Ewopharma has extensive knowledge of these markets and enjoys a privileged position in the area. The company employs more than 320 highly qualified staff in 15 countries. www.ewopharma.com